Topic Editors


Cellular and Molecular Mechanisms of Obesity-Associated Cancer Development and Treatments
Topic Information
Dear Colleagues,
Obesity is a chronic disease characterized by the abnormal or excessive accumulation of body fat. According to data from the World Health Organization (WHO), more than 1 billion people in the world are obese, including 650 million adults, 340 million adolescents, and 39 million children, which will cause about 167 million people to become ill by 2025. The prevalence of obesity is impacted by many genetic and environmental factors, such as sex, race, physical activity, diet, and socioeconomic status. Obesity is commonly associated with many other metabolic disorders, including type 2 diabetes (T2D), metabolic dysfunction-associated steatotic liver disease (MASLD), cardiovascular diseases (CVDs), and chronic kidney diseases (CKDs). Obesity, together with these metabolic disorders, has been identified to promote most cancer progression, including breast cancer, hepatocellular carcinoma (HCC), pancreatic ductal adenocarcinoma (PDAC), and lung and kidney cancers. Therefore, it is essential to understand the underlying cellular and molecular mechanisms involved in the pathogenesis of obesity-associated cancers and develop new targets for cancer treatment. This Topic, entitled “Cellular and Molecular Mechanisms of Obesity-Associated Cancer Development and Treatments”, aims to provide a comprehensive overview of the most recent advances in this field and explore the underlying mechanisms of obesity-associated cancer development and new treatment targets.
Dr. Ming Yang
Dr. Chunye Zhang
Topic Editors
Keywords
- obesity
- cancers
- cellular mechanisms
- molecular targets
- metabolites
- drugs
- diagnosis
- clinical trials
Participating Journals
Journal Name | Impact Factor | CiteScore | Launched Year | First Decision (median) | APC | |
---|---|---|---|---|---|---|
![]()
Cancers
|
4.5 | 8.0 | 2009 | 17.4 Days | CHF 2900 | Submit |
![]()
Current Oncology
|
2.8 | 3.3 | 1994 | 19.8 Days | CHF 2200 | Submit |
![]()
Diseases
|
2.9 | 0.8 | 2013 | 21.4 Days | CHF 1800 | Submit |
![]()
International Journal of Molecular Sciences
|
4.9 | 8.1 | 2000 | 16.8 Days | CHF 2900 | Submit |
![]()
Cells
|
5.1 | 9.9 | 2012 | 17 Days | CHF 2700 | Submit |
Preprints.org is a multidisciplinary platform offering a preprint service designed to facilitate the early sharing of your research. It supports and empowers your research journey from the very beginning.
MDPI Topics is collaborating with Preprints.org and has established a direct connection between MDPI journals and the platform. Authors are encouraged to take advantage of this opportunity by posting their preprints at Preprints.org prior to publication:
- Share your research immediately: disseminate your ideas prior to publication and establish priority for your work.
- Safeguard your intellectual contribution: Protect your ideas with a time-stamped preprint that serves as proof of your research timeline.
- Boost visibility and impact: Increase the reach and influence of your research by making it accessible to a global audience.
- Gain early feedback: Receive valuable input and insights from peers before submitting to a journal.
- Ensure broad indexing: Web of Science (Preprint Citation Index), Google Scholar, Crossref, SHARE, PrePubMed, Scilit and Europe PMC.